Trazodone Hydrochloride USP For Compounding (API)

Trazodone Hydrochloride USP for Compounding (API) is an active pharmaceutical ingredient used to formulate customizable medications primarily for treating depression and anxiety disorders. It functions as a serotonin antagonist and reuptake inhibitor (SARI), helping to balance neurotransmitters in the brain, thereby improving mood and emotional states. Compounding allows pharmacists to create tailored dosages and formulations to meet specific patient needs, especially for those who may not tolerate existing pill sizes or who require alternative delivery methods to enhance therapeutic outcomes.

Trazodone Hydrochloride USP, also known as Trazodone HCl, is an active pharmaceutical ingredient (API) used in the production of medications for the treatment of depression and other mental health conditions. It belongs to a class of chemicals called serotonin modulators, which work by increasing the amount of serotonin (a neurotransmitter) in the brain.
Trazodone HCl is a white, odorless crystalline powder that is highly soluble in water. It is prescribed as a tablet or extended-release tablet and is available in various strengths. It is classified as a prescription drug in the United States and is usually taken orally.

The exact mechanism of action of Trazodone HCl is not fully understood, but it is believed to affect the levels of serotonin and other neurotransmitters in the brain, which are involved in mood regulation. This helps alleviate symptoms of depression and anxiety.

In addition to treating depression, Trazodone HCl may also be used to treat other conditions such as insomnia, chronic pain, and alcohol withdrawal symptoms. It is often combined with other medications to achieve better results.

Trazodone HCl has been approved by the US Food and Drug Administration (FDA) since 1981. It has been shown to be effective in managing symptoms of depression and has a low risk of addiction or abuse. However, like all medications, it may cause side effects in some individuals, including drowsiness, dizziness, headaches, and dry mouth.

Overall, Trazodone HCl is considered a safe and effective active pharmaceutical ingredient for the treatment of depression and other mental health conditions. However, it should only be used under the supervision of a healthcare provider, who can monitor for any potential side effects and adjust the dosage as needed.

Trazodone Hydrochloride USP is a pharmaceutical drug that is primarily used to treat depression, anxiety, and sleep disorders. It is classified as a serotonin antagonist and reuptake inhibitor (SARI) and works by increasing the levels of serotonin, a neurotransmitter that helps regulate mood and sleep patterns, in the brain.

In compounding, Trazodone Hydrochloride USP can be used as a versatile ingredient to create customized medications for patients who may have specific needs or preferences, such as those who cannot take commercially available forms of trazodone, or those who need a different dosage or combination of ingredients. It can be compounded into various forms such as capsules, solutions, suspensions, and creams to meet the individual needs of patients.

Trazodone Hydrochloride USP can also be used in combination with other medications to treat a variety of conditions such as chronic pain, neuropathic pain, and insomnia. It is also commonly used in veterinary medicine to treat behavioral issues and anxiety in animals.

It is important to note that compounding with Trazodone Hydrochloride USP should only be done under the supervision of a licensed healthcare professional. Patients should always consult their healthcare provider before using any compounded medications.

CAS Number: 1197-18-8